002107 沃华医药
已收盘 08-17 15:00:00
资讯
新帖
简况
股市必读:沃华医药新发布《2026年中期权益分派实施公告》
证券之星 · 08-13
股市必读:沃华医药新发布《2026年中期权益分派实施公告》
沃华医药最新公告:2026年中期每10股派现1.17元
证券之星 · 08-11
沃华医药最新公告:2026年中期每10股派现1.17元
沃华医药(002107)披露2026年中期权益分派实施公告,8月11日股价下跌0.79%
证券之星 · 08-11
沃华医药(002107)披露2026年中期权益分派实施公告,8月11日股价下跌0.79%
股市必读:沃华医药新发布《关于沃华医药2026年第二次临时股东会的法律意见书》
证券之星 · 08-03
股市必读:沃华医药新发布《关于沃华医药2026年第二次临时股东会的法律意见书》
沃华医药:目前暂未有创新药项目
证券之星 · 07-21
沃华医药:目前暂未有创新药项目
股市必读:沃华医药中报 - 第二季度单季净利润同比增长41.72%
证券之星 · 07-17
股市必读:沃华医药中报 - 第二季度单季净利润同比增长41.72%
沃华医药(002107)披露2026年半年度报告,7月15日股价上涨7.92%
证券之星 · 07-15
沃华医药(002107)披露2026年半年度报告,7月15日股价上涨7.92%
沃华医药半年报:上半年净利润同比增长51.23%
证券之星 · 07-15
沃华医药半年报:上半年净利润同比增长51.23%
沃华医药:上半年净利同比增51.23%
格隆汇 · 07-15
沃华医药:上半年净利同比增51.23%
沃华医药(002107)披露2026年半年度业绩预告,7月6日股价下跌1.51%
证券之星 · 07-06
沃华医药(002107)披露2026年半年度业绩预告,7月6日股价下跌1.51%
沃华医药:预计2026年1-6月每股收益盈利:0.1126元至0.1386元
证券之星 · 07-06
沃华医药:预计2026年1-6月每股收益盈利:0.1126元至0.1386元
沃华医药最新公告:预计2026年半年度净利润同比增长45.49%-79.07%
证券之星 · 07-06
沃华医药最新公告:预计2026年半年度净利润同比增长45.49%-79.07%
沃华医药:6月10日董事张戈减持股份合计40.7万股
证券之星 · 06-11
沃华医药:6月10日董事张戈减持股份合计40.7万股
沃华医药:6月5日董事张戈减持股份合计94.61万股
证券之星 · 06-08
沃华医药:6月5日董事张戈减持股份合计94.61万股
沃华医药(002107)披露将参加2026年山东辖区上市公司投资者网上集体接待日活动,5月13日股价上涨1.1%
证券之星 · 05-13
沃华医药(002107)披露将参加2026年山东辖区上市公司投资者网上集体接待日活动,5月13日股价上涨1.1%
沃华医药(002107)披露董事减持公司股份预披露公告,5月8日股价下跌2.0%
证券之星 · 05-08
沃华医药(002107)披露董事减持公司股份预披露公告,5月8日股价下跌2.0%
沃华医药:截至3月31日公司股东数量为35491
证券之星 · 04-17
沃华医药:截至3月31日公司股东数量为35491
4月9日沃华医药(002107)涨停分析:业绩高增、外资入驻、新品上市驱动
证券之星 · 04-14
4月9日沃华医药(002107)涨停分析:业绩高增、外资入驻、新品上市驱动
异动快报:沃华医药(002107)4月9日9点38分触及涨停板
证券之星 · 04-09
异动快报:沃华医药(002107)4月9日9点38分触及涨停板
沃华医药(002107)2026年一季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 04-09
沃华医药(002107)2026年一季报简析:营收净利润同比双双增长,盈利能力上升
加载更多
公司概况
公司名称:
山东沃华医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2007-01-24
主营业务:
山东沃华医药科技股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是心脑血管系统药物、肌肉骨骼系统药物、抗病毒类呼吸系统药物、生殖泌尿系统药物。曾荣获国家中药标准化项目、国家重大新药创制、中华民族医药学会科学技术奖一等奖,863计划、国家重大新药创制专项、国家科学技术进步二等奖、山东省科技重大专项、山东省科技技术进步二等奖、中国制药品牌榜新锐品牌、百姓放心药等。
发行价格:
10.85
{"stockData":{"symbol":"002107","market":"SZ","secType":"STK","nameCN":"沃华医药","latestPrice":6.54,"timestamp":1786950180000,"preClose":6.41,"halted":0,"volume":16499040,"delay":0,"changeRate":0.0203,"floatShares":571000000,"shares":577000000,"eps":0.2055,"marketStatus":"已收盘","change":0.13,"latestTime":"08-17 15:00:00","open":6.39,"high":6.59,"low":6.21,"amount":107000000,"amplitude":0.0593,"askPrice":6.54,"askSize":1509,"bidPrice":6.53,"bidSize":1393,"shortable":0,"etf":0,"ttmEps":0.2055,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787016600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.41,"symbolType":"stock","openAndCloseTimeList":[[1786930200000,1786937400000],[1786942800000,1786950000000]],"highLimit":7.05,"lowLimit":5.77,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":577209600,"isCdr":false,"pbRate":5.23,"roa":"--","peRate":31.824818,"roe":"9.44%","epsLYR":0.17,"committee":0.080025,"marketValue":3775000000,"turnoverRate":0.0289,"status":0,"floatMarketCap":3737000000},"requestUrl":"/m/hq/s/002107/","defaultTab":"news","newsList":[{"id":"2659904476","title":"股市必读:沃华医药新发布《2026年中期权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659904476","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659904476?lang=zh_cn&edition=full","pubTime":"2026-08-13 02:08","pubTimestamp":1786558096,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘,沃华医药报收于6.33元,上涨1.28%,换手率1.58%,成交量9.05万手,成交额5711.43万元。当日关注点交易信息汇总:8月12日主力资金净流出142.79万元,占总成交额2.5%。公司公告汇总:沃华医药公布2026年中期权益分派方案,以总股本577,209,600股为基数,每10股派发现金红利1.17元(含税),股权登记日为2026年8月17日,除息日为2026年8月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300001407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911221","title":"沃华医药最新公告:2026年中期每10股派现1.17元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658911221?lang=zh_cn&edition=full","pubTime":"2026-08-11 23:39","pubTimestamp":1786462789,"startTime":"0","endTime":"0","summary":"沃华医药(002107.SZ)公告称,公司2026年中期权益分派方案已获股东会审议通过,向全体股东每10股派发现金红利1.17元(含税),共计派发6753.35万元(含税)。股权登记日为2026年8月17日,除息日为2026年8月18日。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916129","title":"沃华医药(002107)披露2026年中期权益分派实施公告,8月11日股价下跌0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658916129?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:13","pubTimestamp":1786457596,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘,沃华医药报收于6.25元,较前一交易日下跌0.79%,最新总市值为36.08亿元。该股当日开盘6.26元,最高6.35元,最低6.24元,成交额达5969.14万元,换手率为1.66%。近日,沃华医药发布《2026年中期权益分派实施公告》。本次权益分派股权登记日为2026年8月17日,除息日为2026年8月18日,现金红利由中国结算深圳分公司代派或公司自行派发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343430","title":"股市必读:沃华医药新发布《关于沃华医药2026年第二次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343430?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:14","pubTimestamp":1785698052,"startTime":"0","endTime":"0","summary":"公司公告汇总关于沃华医药2026年第二次临时股东会的法律意见书北京市星河律师事务所就山东沃华医药科技股份有限公司2026年第二次临时股东会的召集召开程序、出席会议人员资格、表决程序及表决结果等事项出具法律意见书。2026年第二次临时股东会决议公告山东沃华医药科技股份有限公司于2026年7月31日召开2026年第二次临时股东会,会议由董事会召集,采用现场与网络投票相结合方式召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653973270","title":"沃华医药:目前暂未有创新药项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2653973270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653973270?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:51","pubTimestamp":1784638286,"startTime":"0","endTime":"0","summary":"证券之星消息,沃华医药(002107)07月20日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司有创新药项目吗?沃华医药回复:尊敬的投资者您好!公司目前聚焦于心脑血管、骨骼肌肉、代谢健康等慢病领域的中成药研发,不排除在条件、时机成熟时通过新产品收购或资本运营方式获得与现有产品线形成协同效应的新产品。目前暂未有创新药项目。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100042280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107","BK1161","06978","159992","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652342627","title":"股市必读:沃华医药中报 - 第二季度单季净利润同比增长41.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652342627","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652342627?lang=zh_cn&edition=full","pubTime":"2026-07-17 01:38","pubTimestamp":1784223489,"startTime":"0","endTime":"0","summary":"股本股东变化:截至2026年6月30日股东户数增至3.86万户,较3月31日增长8.82%,户均持股量下降至1.49万股。业绩披露要点:2026年中报显示归母净利润6756.63万元,同比上升51.23%,但上半年主营收入同比下降7.53%至3.93亿元。2026年第二季度:单季度主营收入1.74亿元,同比下降16.01%;单季度归母净利润3091.76万元,同比上升41.72%;单季度扣非净利润3021.53万元,同比上升46.12%;负债率26.32%,财务费用-35.73万元,毛利率77.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700000880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651697474","title":"沃华医药(002107)披露2026年半年度报告,7月15日股价上涨7.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651697474","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651697474?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:12","pubTimestamp":1784124741,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘,沃华医药报收于6.95元,较前一交易日上涨7.92%,最新总市值为40.12亿元。该股当日开盘6.38元,最高6.96元,最低6.37元,成交额达2.23亿元,换手率为5.8%。近日,沃华医药披露2026年半年度报告。报告显示,本报告期营业收入为393,349,512.77元,同比下降7.53%;归属于上市公司股东的净利润为67,566,295.15元,同比增长51.23%;扣除非经常性损益后的净利润为65,959,000.12元,同比增长54.34%。经营活动产生的现金流量净额为81,367,502.48元,同比增长8.07%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500044731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651650534","title":"沃华医药半年报:上半年净利润同比增长51.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651650534","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651650534?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:11","pubTimestamp":1784121062,"startTime":"0","endTime":"0","summary":"沃华医药(002107.SZ)公告称,公司发布2026年半年度报告,实现营业收入3.93亿元,同比下降7.53%;归属于上市公司股东的净利润6756.63万元,同比增长51.23%。公司拟向全体股东每10股派发现金红利1.17元(含税)。注:公司Q2净利润0.31亿,Q1净利润0.37亿,据此计算,Q2净利润环比下降15%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500043554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651269465","title":"沃华医药:上半年净利同比增51.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651269465","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651269465?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:08","pubTimestamp":1784120885,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649151620","title":"沃华医药(002107)披露2026年半年度业绩预告,7月6日股价下跌1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649151620","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649151620?lang=zh_cn&edition=full","pubTime":"2026-07-06 23:04","pubTimestamp":1783350262,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘,沃华医药报收于6.54元,较前一交易日下跌1.51%,最新总市值为37.75亿元。该股当日开盘6.49元,最高6.66元,最低6.43元,成交额达1.09亿元,换手率为2.93%。近日,沃华医药披露《2026年半年度业绩预告》。公告显示,公司预计2026年上半年归属于上市公司股东的净利润为6,500万元至8,000万元,同比增长45.49%至79.07%;扣除非经常性损益后的净利润为6,380万元至7,750万元,同比增长49.29%至81.35%。该数据为初步测算结果,未经审计,最终以2026年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600038140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649629009","title":"沃华医药:预计2026年1-6月每股收益盈利:0.1126元至0.1386元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649629009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649629009?lang=zh_cn&edition=full","pubTime":"2026-07-06 20:00","pubTimestamp":1783339227,"startTime":"0","endTime":"0","summary":"证券之星消息,沃华医药发布业绩预告,预计2026年1-6月每股收益盈利:0.1126元至0.1386元。最终,归属于上市公司股东的净利润实现较大幅度增长,经营利润显著提升。沃华医药2026年一季报显示,一季度公司主营收入2.19亿元,同比上升0.55%;归母净利润3664.87万元,同比上升60.32%;扣非净利润3574.37万元,同比上升62.05%;负债率28.76%,财务费用-18.82万元,毛利率77.96%。本文数据来源于《沃华医药:山东沃华医药科技股份有限公司2026年半年度业绩预告》,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600032765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649262322","title":"沃华医药最新公告:预计2026年半年度净利润同比增长45.49%-79.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649262322","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649262322?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:31","pubTimestamp":1783333878,"startTime":"0","endTime":"0","summary":"沃华医药(002107.SZ)公告称,预计2026年半年度归属于上市公司股东的净利润为6500万元-8000万元,同比增长45.49%-79.07%。业绩变动主要系公司推动精细化管理与运营,深化降本增效,优化产品结构,调整市场结构,实现经营利润显著提升。注:公司Q2净利润预计0.28亿-0.43亿,Q1净利润0.37亿,据此计算,Q2净利润预计环比变动-22%-18%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600029584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642282403","title":"沃华医药:6月10日董事张戈减持股份合计40.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642282403","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642282403?lang=zh_cn&edition=full","pubTime":"2026-06-11 21:01","pubTimestamp":1781182877,"startTime":"0","endTime":"0","summary":"证券之星消息,根据6月11日市场公开信息、上市公司公告及交易所披露数据整理,沃华医药(002107)最新董监高及相关人员股份变动情况:2026年6月10日公司董事,董秘张戈共减持公司股份40.7万股,占公司总股本为0.0705%。变动期间公司股价下跌1.33%,6月10日当日收盘报5.92元。沃华医药近半年内的董监高及核心技术人员增减持详情如下:沃华医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、沃华医药公告,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100036421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641482513","title":"沃华医药:6月5日董事张戈减持股份合计94.61万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641482513","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641482513?lang=zh_cn&edition=full","pubTime":"2026-06-08 21:01","pubTimestamp":1780923679,"startTime":"0","endTime":"0","summary":"证券之星消息,根据6月8日市场公开信息、上市公司公告及交易所披露数据整理,沃华医药(002107)最新董监高及相关人员股份变动情况:2026年6月5日公司董事,董秘张戈共减持公司股份94.61万股,占公司总股本为0.1639%。变动期间公司股价上涨0.16%,6月5日当日收盘报6.22元。沃华医药近半年内的董监高及核心技术人员增减持详情如下:沃华医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800033276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635853137","title":"沃华医药(002107)披露将参加2026年山东辖区上市公司投资者网上集体接待日活动,5月13日股价上涨1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635853137","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635853137?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:36","pubTimestamp":1778668612,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘,沃华医药报收于7.34元,较前一交易日上涨1.1%,最新总市值为42.37亿元。该股当日开盘7.3元,最高7.5元,最低7.27元,成交额达1.49亿元,换手率为3.52%。沃华医药于近日披露《关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告》。公告显示,公司将于2026年5月15日15:00-16:30通过网络远程方式参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的“2026年山东辖区上市公司投资者网上集体接待日活动”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300034802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633439055","title":"沃华医药(002107)披露董事减持公司股份预披露公告,5月8日股价下跌2.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633439055","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633439055?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:33","pubTimestamp":1778232833,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,沃华医药报收于7.36元,较前一交易日下跌2.0%,最新总市值为42.48亿元。近日,沃华医药披露《关于董事减持公司股份的预披露公告》。公告显示,公司董事、董事会秘书张戈先生持有公司7,544,065股,占总股本1.31%,计划自2026年6月1日至8月31日,通过集中竞价方式减持不超过1,886,016股,即不超过公司总股本的0.33%。张戈先生承诺将遵守相关法律法规及承诺要求进行减持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628209998","title":"沃华医药:截至3月31日公司股东数量为35491","url":"https://stock-news.laohu8.com/highlight/detail?id=2628209998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2628209998?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:51","pubTimestamp":1776430319,"startTime":"0","endTime":"0","summary":"证券之星消息,沃华医药(002107)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,你好!麻烦告知一下4月10日的股东户数是多少,跪谢了!沃华医药回复:尊敬的投资者您好!关于股东户数的相关问题,您可通过查阅公司披露的定期报告了解最新股东人数。截至3月31日公司股东数量为35491 。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700043113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627413479","title":"4月9日沃华医药(002107)涨停分析:业绩高增、外资入驻、新品上市驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2627413479","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627413479?lang=zh_cn&edition=full","pubTime":"2026-04-14 15:38","pubTimestamp":1776152326,"startTime":"0","endTime":"0","summary":"证券之星消息,沃华医药4月14日涨停收盘,收盘价7.83元。该股于9点39分涨停,1次打开涨停,截止收盘封单资金为1.26亿元,占其流通市值2.81%。4月14日的资金流向数据方面,主力资金净流入1.54亿元,占总成交额34.98%,游资资金净流出5646.19万元,占总成交额12.79%,散户资金净流出9796.69万元,占总成交额22.19%。近5日资金流向一览见下表:该股为医药,中药,阿尔茨海默病概念热股,当日医药概念上涨0.94%,中药概念上涨0.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400020110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626971481","title":"异动快报:沃华医药(002107)4月9日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2626971481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2626971481?lang=zh_cn&edition=full","pubTime":"2026-04-09 09:45","pubTimestamp":1775699151,"startTime":"0","endTime":"0","summary":"证券之星4月9日盘中消息,9点38分沃华医药触及涨停板。其所属行业中药目前上涨。该股为中药,医药,阿尔茨海默病概念热股,当日中药概念上涨1.16%,医药概念上涨0.86%,阿尔茨海默病概念上涨0.42%。4月8日的资金流向数据方面,主力资金净流入2587.74万元,占总成交额8.26%,游资资金净流入3057.58万元,占总成交额9.76%,散户资金净流出5645.32万元,占总成交额18.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900008609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626978804","title":"沃华医药(002107)2026年一季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2626978804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2626978804?lang=zh_cn&edition=full","pubTime":"2026-04-09 06:03","pubTimestamp":1775685813,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期沃华医药发布2026年一季报。截至本报告期末,公司营业总收入2.19亿元,同比上升0.55%,归母净利润3664.87万元,同比上升60.32%。本报告期沃华医药盈利能力上升,毛利率同比增幅6.79%,净利率同比增幅72.93%。去年的净利率为10.87%,算上全部成本后,公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900003206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787010164809,"stockEarnings":[{"period":"1week","weight":0.0381},{"period":"1month","weight":0.0332},{"period":"3month","weight":-0.063},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0279},{"period":"ytd","weight":0.0709}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.058},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.0244},{"period":"1year","weight":0.0773},{"period":"ytd","weight":0.0035}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东沃华医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38620人(较上一季度增加8.82%)","perCapita":"14795股","listingDate":"2007-01-24","address":"山东省潍坊市奎文区高新技术产业开发区梨园街3517号","registeredCapital":"57720万元","survey":" 山东沃华医药科技股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是心脑血管系统药物、肌肉骨骼系统药物、抗病毒类呼吸系统药物、生殖泌尿系统药物。曾荣获国家中药标准化项目、国家重大新药创制、中华民族医药学会科学技术奖一等奖,863计划、国家重大新药创制专项、国家科学技术进步二等奖、山东省科技重大专项、山东省科技技术进步二等奖、中国制药品牌榜新锐品牌、百姓放心药等。","listedPrice":10.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沃华医药(002107)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沃华医药(002107)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沃华医药,002107,沃华医药股票,沃华医药股票老虎,沃华医药股票老虎国际,沃华医药行情,沃华医药股票行情,沃华医药股价,沃华医药股市,沃华医药股票价格,沃华医药股票交易,沃华医药股票购买,沃华医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沃华医药(002107)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沃华医药(002107)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}